ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Pulmonary Disease

Top Pulmonary Disease Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAGDEEP BIJWADIA MD, FCCP, DABSM

Pulmonary Disease

5,518

$277K

171
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 55%

$50
Average prescription price

Avg: $195

MARSHALL HERTZ M.D.

Pulmonary Disease

3,679

$465K

135
53 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 55%

$126
Average prescription price

Avg: $195

KATHY GROMER M.D.

Pulmonary Disease

3,129

$605K

465
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 55%

$193
Average prescription price

Avg: $195

JORDAN DUNITZ M.D.

Pulmonary Disease

2,768

$865K

102
20 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 55%

$313
Average prescription price

Avg: $195

JAGADISH PATIL M.D.

Pulmonary Disease

2,652

$440K

142
53 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 55%

$166
Average prescription price

Avg: $195

CHARLES GENSMER M.D.

Pulmonary Disease

2,554

$665K

385
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 55%

$261
Average prescription price

Avg: $195

MICHAEL MOSLETH M.D.

Pulmonary Disease

2,420

$117K

426
395 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 55%

$48
Average prescription price

Avg: $195

CHARLENE MCEVOY MD

Pulmonary Disease

2,013

$337K

233
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 55%

$167
Average prescription price

Avg: $195

PATRICK WRIGHT M.D.

Pulmonary Disease

1,965

$532K

290
221 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 55%

$271
Average prescription price

Avg: $195

JOAN FOX M.D.

Pulmonary Disease

1,876

$664K

261
206 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 55%

$354
Average prescription price

Avg: $195

TODD GREATENS MD

Pulmonary Disease

1,868

$337K

238
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 55%

$181
Average prescription price

Avg: $195

WILLIAM BRUTINEL M.D.

Pulmonary Disease

1,752

$330K

138
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 55%

$189
Average prescription price

Avg: $195

JEANNE NELSON MD

Pulmonary Disease

1,624

$272K

203
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 55%

$167
Average prescription price

Avg: $195

NICOLETTE MYERS

Pulmonary Disease

1,606

$274K

208
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 55%

$171
Average prescription price

Avg: $195

ASRA MOHIUDDIN

Pulmonary Disease

1,587

$326K

293
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 55%

$206
Average prescription price

Avg: $195

KEITH HARMON MD

Pulmonary Disease

1,538

$295K

231
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 55%

$192
Average prescription price

Avg: $195

SALIM KATHAWALLA M.D.

Pulmonary Disease

1,536

$454K

252
207 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 55%

$295
Average prescription price

Avg: $195

SHELLEY LENNOX M.D.

Pulmonary Disease

1,361

$232K

211
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 55%

$170
Average prescription price

Avg: $195

JERAY JOHNSON MD

Pulmonary Disease

1,323

$237K

172
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 55%

$179
Average prescription price

Avg: $195

DAVID SHUSTER MD

Pulmonary Disease

1,218

$334K

158
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 55%

$274
Average prescription price

Avg: $195

BLAIR ANDERSON MD

Pulmonary Disease

1,174

$209K

166
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 55%

$178
Average prescription price

Avg: $195

RALPH STEELE M.D.

Pulmonary Disease

1,170

$201K

201
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 55%

$172
Average prescription price

Avg: $195

ROBERT BOWEN M.D.

Pulmonary Disease

1,097

$264K

193
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 55%

$241
Average prescription price

Avg: $195

LINDA FUNK M.D.

Pulmonary Disease

1,072

$214K

156
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 55%

$199
Average prescription price

Avg: $195

JOSEPH MARTINELLI MD

Pulmonary Disease

1,056

$422K

242
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 55%

$399
Average prescription price

Avg: $195

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank